Home › Acute Myeloid Leukemia › Georgia › Savannah
Acute Myeloid Leukemia clinical trials in Savannah, GA
3 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Savannah (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Low Country Cancer Care, Savannah
- Memorial Health University Medical Center, Savannah
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecruitingPhase 3
- Memorial Health University Medical Center, Savannah
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Memorial Health University Medical Center, Savannah
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Seattle, WA41 studies
- Baldwin Park, CA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA31 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Savannah
- Breast Cancer11 studies
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer10 studies
- Cancer (all types)6 studies
- Major Depressive Disorder6 studies
- Type 2 Diabetes6 studies
- Melanoma5 studies
- COPD5 studies
- Ovarian Cancer4 studies
- Colorectal Cancer4 studies
- Non-Hodgkin Lymphoma3 studies
- Mania3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.